Article

Pharmaceutical Executive

Pharmaceutical Executive

Pharmaceutical Executive-05-01-2001
Volume0
Issue 0

Political Science

Author(s):

Jill Wechsler, Pharm Exec’s Washington Correspondent

Concern that gene and stem-cell research could lead to human cloning has generated proposals for legislative bans, which could block promising research.

Articles in this issue
Policy: Task Masters
Pharmacia's Carrie Cox: HBA Woman of the Year
Friends of Complexity
Under Federal Fire
Task Force: Enter the Fixers
The Next Y2K

Newsletter

Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

Subscribe Now!
Related Videos
Michael Grosberg
Related Content
Stock.adobe.com
August 25th 2025

U.S. CDC Elects mRNA Vaccine Critic to Lead Covid-19 Immunization Workgroup

Nicholas Jacobus
The Rx for High-Performance Leadership: Cutting Through the Chaos
August 25th 2025

The Rx for High-Performance Leadership: Cutting Through the Chaos

Michael Christel
AbbVie Expands Psychiatry Drug Pipeline with Acquisition of Gilgamesh Pharmaceuticals’ Bretisilocin for Major Depressive Disorder
August 25th 2025

AbbVie Expands Psychiatry Drug Pipeline with Acquisition of Gilgamesh Pharmaceuticals’ Bretisilocin for Major Depressive Disorder

Don Tracy, Associate Editor
Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research
August 25th 2025

Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research

Miranda Schmalfuhs
Stock.adobe.com
August 25th 2025

Valneva Reveals FDA’s Decision to Suspend Ixchiq’s License in the U.S.

Nicholas Jacobus
Edward Barrett, PhD
August 25th 2025

Bridging Innovation and Reliability: Why Animal Studies Still Matter in the Age of NAMs

Edward G. Barrett, PhD